Polyethylene Wear Particle Analysis of THA
Launched by OSAKA METROPOLITAN UNIVERSITY · May 22, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new type of material called Vitamin E-containing polyethylene, which is used in hip replacement surgeries. Researchers want to find out if this new material causes less wear and tear compared to the traditional polyethylene used in hip replacements. Understanding how much wear this material produces is important because it could lead to better long-term outcomes for patients who have hip replacements.
To participate in this study, you need to be over 20 years old and scheduled for a revision hip surgery. You should also have had your first hip replacement at least two years ago. If you join the trial, you'll help researchers learn more about how these materials perform in real-life situations, which could benefit future patients. Before participating, you'll receive a thorough explanation of the study and will need to provide written consent to ensure you understand everything involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients undergoing revision hip arthroplasty within the study period
- • 2. Patients over 20 years old
- • 3. Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
- • 4. Patients who have passed 2 years or more since their first total hip arthroplasty
- Exclusion Criteria:
- • 1. Patients who are judged to be unsuitable as research subjects by the research physician
Trial Officials
Yukihide Minoda, MD, PhD
Principal Investigator
Osaka Metropolitan University
About Osaka Metropolitan University
Osaka Metropolitan University is a leading academic institution in Japan that emphasizes innovative research and development in the field of healthcare. As a clinical trial sponsor, the university leverages its extensive expertise in biomedical sciences and collaboration with multidisciplinary teams to advance medical knowledge and improve patient outcomes. The institution is committed to conducting rigorous and ethically sound clinical trials that contribute to the understanding of various diseases and the efficacy of new treatments, thereby fostering advancements in public health and clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Osaka, , Japan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0